By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Janssen Biotech Inc. 

800 Ridgeview Drive

Horsham  Pennsylvania  19044  U.S.A.
Phone: 888-227-5624 Fax: n/a


SEARCH JOBS








Company News
Janssen Biotech (JNJ) Enters Immunotherapy Clinical Collaboration With Bristol-Myers Squibb (BMY) To Evaluate Daratumumab (DARZALEX) In Combination With Nivolumab (OPDIVO) 1/5/2017 6:21:11 AM
Janssen Biotech (JNJ) Submits Two Applications To FDA Seeking Approval Of SIMPONI ARIA (Golimumab) For The Treatment Of Active Psoriatic Arthritis And Active Ankylosing Spondylitis 12/21/2016 7:47:53 AM
Janssen Biotech (JNJ) Submits Application Seeking FDA Approval Of STELARA (Ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis 12/16/2016 7:03:00 AM
Janssen Biotech (JNJ) Submits Application To FDA Seeking Approval Of Anti-Interleukin-23 Monoclonal Antibody Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis 11/17/2016 7:01:16 AM
Janssen Biotech (JNJ) Release: Two Studies Reveal Differences In Real-World Treatment Patterns In Rheumatoid Arthritis Patients Taking REMICAD (infliximab) Compared To CT-P13 (infliximab biosimilar) 11/14/2016 9:22:26 AM
Amgen (AMGN) Announces Collaboration With Janssen Biotech (JNJ) To Co-Fund Studies With KYPROLIS (Carfilzomib) And DARZALEX (Daratumumab) In Patients With Multiple Myeloma 11/10/2016 3:27:38 PM
Chengdu's HitGen Collaborates With Janssen Biotech (JNJ) On Oncology And Metabolics Discovery 10/4/2016 8:22:47 AM
Janssen Biotech (JNJ) Release: FDA Approves STELARA (ustekinumab) For Treatment Of Adults With Moderately To Severely Active Crohn's Disease 9/26/2016 8:16:26 AM
Janssen Biotech (JNJ) Submits Application Seeking Approval Of Sirukumab In United States For Rheumatoid Arthritis 9/23/2016 8:29:29 AM
Janssen Biotech (JNJ) Submits Application To U.S. FDA To Expand Indication For Daratumumab (DARZALEX) 8/18/2016 6:47:40 AM
12345678910...
//-->